Sen. Cassidy Suggests Importing Generics From EU To Pressure US Prices
Idea may require tweaking existing agreements between FDA and EMA, but is another twist on drug importation, a concept that FDA opposes.
You may also be interested in...
Upcoming House Oversight Committee hearing on drug pricing offers a chance for fireworks, but broader prospects for new Democratic pricing legislation seem limited.
To remain shielded from political forces that could change incentives, pharmaceutical industry must adopt 'a certain set of values,' US FDA Commissioner says.
Agency eager to hear suggestions on the subject, also known as product hopping, but even reform advocates were cautious of stifling meaningful reformulations of products.